Search

everythinglearnresearchcommunity

for

Search:↓

Serum ferritin is a better indicator than hemoglobin for detecting low iron in women with chronic hair loss.

Serum ferritin levels do not cause hair loss in women with telogen effluvium.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Serum triglyceride levels are not linked to prostate cancer risk.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Men with androgenetic alopecia have unique metabolomic patterns that could help develop targeted treatments.

Low vitamin D levels are linked to higher rates of hair loss in women.

Low levels of vitamin D and ferritin may increase the risk of female pattern hair loss.

People with early onset hair loss (Androgenetic Alopecia) in Ile-Ife, Nigeria, have significantly lower iron levels compared to those with adult-onset hair loss.

AGA patients have lower serum vaspin levels, which might help detect the condition early.

Women with pattern hair loss may have more stress in their bodies due to a lack of NRF2, a protein. Eating healthy and losing weight could help reduce this stress and improve hair loss. NRF2 boosters might also help treat this type of hair loss.

The serum increased hair density and was well-tolerated, but didn't affect hair thickness or shedding.

Female patients with androgenetic alopecia have low serum ferritin levels.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

Low PON1 levels may indicate and predict the severity of hair loss.

Low Vitamin D levels are linked to female hair loss.

Androgenetic alopecia is linked to a higher risk of coronary heart disease due to certain genetic factors and high homocysteine levels.

Females with androgenic alopecia have significantly lower vitamin D3 and ferritin levels.

No strong link between testosterone or DHEAS levels and acne or hair loss in females.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

Higher serum androgens contribute to male pattern baldness.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Men with male pattern baldness don't necessarily have high levels of Dehydroepyandrosterone-sulfate, and there's no link between its levels and the severity of hair loss.

Smoking and drinking can lower vitamin levels and potentially trigger early hair loss, but overall vitamin levels don't seem to affect hair loss duration.

Men with hair loss don't necessarily have higher levels of the hormone DHEA-S, but this hormone tends to decrease with age.